In the past, drug formulation and efficient drug administration to patients was enough to ensure that pharmaceutical companies remained competitive in the marketplace.
The proliferation of drug pipelines and consumer technology have created a two-part delivery and support ecosystem that will be key to developing differentiated combination products. This ecosystem includes drug delivery and support that requires technology to enable increasingly complex delivery solutions, as well as the connectedness and expectations of key stakeholders including payers, regulators, health care professionals, and patients.
While increasingly novel and complex delivery solutions not only administer higher doses over longer periods of time, they are also keeping pace with the personalization and consumerization of healthcare through web-based technology support systems that track doses, share information with healthcare providers, quantify therapy adherence directly tied to payer reimbursement, educate patients and connect them to larger disease state communities.
Recognizing the presence and interconnectedness of this ecosystem and giving both delivery and support equal weight in decision-making for delivery device development is the leading opportunity for pharma manufacturers to increase patient adherence and remain competitive in today’s marketplace.
To learn more about this topic, contact us.